Package 42571-381-01

{"route": ["ORAL"], "spl_id": "fa3753a6-a410-6ae8-e053-6394a90a0106", "openfda": {"upc": ["0342571381011"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["cd820fcb-b6a8-43f4-a6d9-f94546d380c8"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (42571-381-01)", "package_ndc": "42571-381-01", "marketing_start_date": "20221001"}], "brand_name": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "product_id": "42571-381_fa3753a6-a410-6ae8-e053-6394a90a0106", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "42571-381", "dea_schedule": "CIV", "generic_name": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA215835", "marketing_category": "ANDA", "marketing_start_date": "20221001", "listing_expiration_date": "20261231"}